Stéphane Degove – CEO & CFO
Stéphane has 17 years’ experience in Biotech/Pharma and Strategy. Graduated from ESCP (majoring in Finance), he worked at Sanofi in Finance and was co-founder and CFO of a biotechnology company in cancer and thrombosis, Endotis Pharma. Under his leadership, Endotis Pharma raised € 37 million from international funds and built a portfolio of innovative products developed up to Phase II.
Jean-François Prost, MD – VP R&D and Strategy
Jean-François is a Senior Executive of the French and International pharmaceutical industry. Physician specialist in Internal Medicine, Dr. Prost has an experience of 30 years in the industry, having served as Cardiovascular Development Director then Research Director at Servier, R&D Director at Pierre Fabre Medicament and then UCB Pharma, and finally in the last ten years, Scientific and Medical Management at LFB.
Isabelle Tabah-Fisch, MD – Chief Medical Officer
Isabelle is a medical oncologist with over 25 years’ experience in drug development and medical affairs in the pharmaceutical industry. Prior to joining GamaMabs, she held various positions at Sanofi, including VP, Research & Development, VP, Corporate Medical Affairs and VP, Head of the Global Oncology Franchise. She has been involved in the clinical development and marketing of lead cytotoxic agents (Eloxatin, Taxotere, Jevtana) and monoclonal antibodies (Zaltrap, seribantumab). She also collaborated with a number of European and US-based biotech companies.
Jean-Marc Barret, PhD – Pharmacology Manager